Healthy volunteers test new drug formulas in Early-Stage safety trial
NCT ID NCT07364877
First seen Feb 01, 2026 · Last updated Jun 18, 2026 · Updated 12 times
Summary
This early-stage trial tests the safety and how the body processes two versions of an experimental drug, DW4421 and DW4421S, in 38 healthy adults aged 19 to 50. Participants receive a single dose of each drug in random order and are monitored for side effects and drug levels in the blood. The study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chungbuk National University Hospital
Cheongju-si, South Korea
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.